Business & Economics
Health Expenditures
100%
Price Risk
98%
Reimbursement
91%
Incentives
91%
Pharmaceuticals
72%
R and D
63%
Drugs
42%
Price of Risk
29%
Risk Aversion
26%
Certainty Equivalent
18%
Risk Preferences
13%
Utility Function
12%
Expected Utility
9%
Constant Relative Risk Aversion
9%
National Health Insurance
9%
Relative Risk Aversion
9%
Predictability
9%
Firm Risk
8%
Discounted Cash Flow
8%
Price Premium
8%
Information Disclosure
7%
Futures Prices
7%
Risk Premium
7%
Discount Rate
7%
Risk-averse
6%
Burden
6%
Japan
5%
Simulation
4%
Government
4%
Social Sciences
pharmaceutical
81%
expenditures
77%
incentive
67%
firm
44%
health
39%
drug
20%
risk premiums
7%
financial situation
5%
premium
4%
health insurance
4%
simulation
3%
Japan
3%
dialogue
3%
market
2%
literature
1%